HealthExelixis Cabometyx, Pfizer Sutent Compete In Kidney Cancer Clinical Trial Cabozantinib was found to improve progression-free survival in metastatic renal cell carcinoma. A clinical study for the treatment of metastatic kidney cancer suggested cabozantinib will potentially become a first-line treatment.by Livia Rusu
HealthLung Cancer Treatment: Keytruda Better Than Chemotherapy In Patients With Non-Small Cell Lung Cancerby Rhodi Lee
HealthTesaro, ENGOT Announce Successful Phase 3 Clinical Trial Results For Ovarian Cancer Drug Niraparibby Saranya Palanisamy
HealthImmunotherapy Drug Extends Survival Rate Of Head And Neck Cancer Patients With Fewer Side Effectsby Rhodi Lee
HealthMylan Pays Medicaid $465 Million For Overpriced EpiPens: What Are The Most Expensive Drugs In America?by Dianne Depra
HealthDamian Marley, Entrepreneur: Bob Marley’s Youngest Son Converting A Former California Prison Into A Pot Farmby Livia Rusu
Health'Executioner' Protein Responsible For Brain Cell Death In Strokes, Alzheimer’s Diseaseby Livia Rusu
HealthResearchers Identify New Therapeutic Target To Treat Compulsive Binge Eatingby Saranya Palanisamy